🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a multi-center, open-label study to assess the efficacy and safety ...
Status
Completed
Location
University of South Florida
Start Date
2008-05
Trial ID
NCT00634569
Treatments Being Tested
Tegoprubart (AT-1501) is a monoclonal antibody. Antibodies are Y-shaped pro...
Status
Active Not Recruiting
Location
University of Chicago
Start Date
2024-03-04
Trial ID
NCT06305286
Treatments Being Tested
Context: Soluble CD40 ligand (sCD40L) released from activated platelets ind...
Status
Completed
Location
University of Cologne
Start Date
2005-01
Trial ID
NCT01112137
Treatments Being Tested
This study investigates gene abnormalities in Primary Immune Deficiency(PID...
Status
Terminated
Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Start Date
2005-12-14
Trial ID
NCT00266513
The purpose of this study is to test a new way of treating the most common ...
Status
Terminated
Location
Albert Einstein College of Medicine
Start Date
2021-01-01
Trial ID
NCT04491084
Treatments Being Tested
This research study is to determine the safety and dosage of special cells ...
Status
Completed
Location
Texas Children's Hospital GCRC
Start Date
1999-06
Trial ID
NCT00058799
Treatments Being Tested
This is a clinical trial of bone marrow transplantation for patients with t...
Status
Completed
Location
Children Hospital Los Angeles
Start Date
2008-08
Trial ID
NCT00730314
Treatments Being Tested
Blood platelets play a major role in the inflammatory response. A dysregula...
Status
Completed
Location
Hôpital Haut Lévêque
Start Date
2020-11-09
Trial ID
NCT04080453
Treatments Being Tested
This research study is being done to find out if the immunotherapy drugs ca...
Status
Recruiting
Location
University of Chicago Comprehensive Cancer Center
Start Date
2022-04-20
Trial ID
NCT05029999
Treatments Being Tested
This is a study to determine the maximum tolerated dose (MTD) for CDX-1140 ...
Status
Completed
Location
HonorHealth Research Insititute
Start Date
2017-12-01
Trial ID
NCT03329950
Treatments Being Tested